BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 33246141)

  • 41. Progress in Small Molecule and Biologic Therapeutics Targeting Ghrelin Signaling.
    McGovern KR; Darling JE; Hougland JL
    Mini Rev Med Chem; 2016; 16(6):465-80. PubMed ID: 26202202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver-expressed antimicrobial peptide 2 antagonizes the effect of ghrelin in rodents.
    Islam MN; Mita Y; Maruyama K; Tanida R; Zhang W; Sakoda H; Nakazato M
    J Endocrinol; 2020 Jan; 244(1):13-23. PubMed ID: 31539874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of ghrelin in energy balance and body weight homeostasis.
    Mihalache L; Gherasim A; Niţă O; Ungureanu MC; Pădureanu SS; Gavril RS; Arhire LI
    Hormones (Athens); 2016 Feb; 15(2):186-196. PubMed ID: 27376422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and Metabolic Profiling of a Novel Human Gut-derived LEAP2 Fragment.
    Hagemann CA; Zhang C; Hansen HH; Jorsal T; Rigbolt KTG; Madsen MR; Bergmann NC; Heimbürger SMN; Falkenhahn M; Theis S; Breitschopf K; Holm S; Hedegaard MA; Christensen MB; Vilsbøll T; Holst B; Vrang N; Jelsing J; Knop FK
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e966-e981. PubMed ID: 33135737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes.
    Rodríguez A; Gómez-Ambrosi J; Catalán V; Gil MJ; Becerril S; Sáinz N; Silva C; Salvador J; Colina I; Frühbeck G
    Int J Obes (Lond); 2009 May; 33(5):541-52. PubMed ID: 19238155
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ghrelin, a gastrointestinal hormone, regulates energy balance and lipid metabolism.
    Lv Y; Liang T; Wang G; Li Z
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30177523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The β-cell GHSR and downstream cAMP/TRPM2 signaling account for insulinostatic and glycemic effects of ghrelin.
    Kurashina T; Dezaki K; Yoshida M; Sukma Rita R; Ito K; Taguchi M; Miura R; Tominaga M; Ishibashi S; Kakei M; Yada T
    Sci Rep; 2015 Sep; 5():14041. PubMed ID: 26370322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ghrelin's second life: from appetite stimulator to glucose regulator.
    Verhulst PJ; Depoortere I
    World J Gastroenterol; 2012 Jul; 18(25):3183-95. PubMed ID: 22783041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ghrelin in the control of energy, lipid, and glucose metabolism.
    Heppner KM; Müller TD; Tong J; Tschöp MH
    Methods Enzymol; 2012; 514():249-60. PubMed ID: 22975057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-Fat Diet Induces Resistance to Ghrelin and LEAP2 Peptide Analogs in Mice.
    Holá L; Tureckiuová T; Kuneš J; Železná B; Maletínská L
    Physiol Res; 2023 Nov; 72(5):607-619. PubMed ID: 38015760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What is the real relevance of endogenous ghrelin?
    Al Massadi O; López M; Fernø J; Diéguez C; Nogueiras R
    Peptides; 2015 Aug; 70():1-6. PubMed ID: 26003396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of peripheral ghrelin signaling via the vagus nerve in ghrelin receptor-restored GHSR-null mice.
    Okada T; Waise TMZ; Toshinai K; Mita Y; Sakoda H; Nakazato M
    Neurosci Lett; 2018 Aug; 681():50-55. PubMed ID: 29802915
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ghrelin and ghrelin receptor inhibitors: agents in the treatment of obesity.
    Soares JB; Roncon-Albuquerque R; Leite-Moreira A
    Expert Opin Ther Targets; 2008 Sep; 12(9):1177-89. PubMed ID: 18694382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ghrelin--a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues.
    Chollet C; Meyer K; Beck-Sickinger AG
    J Pept Sci; 2009 Nov; 15(11):711-30. PubMed ID: 19787814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ghrelin as a Survival Hormone.
    Mani BK; Zigman JM
    Trends Endocrinol Metab; 2017 Dec; 28(12):843-854. PubMed ID: 29097101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ghrelin regulates insulin release and glycemia: physiological role and therapeutic potential.
    Yada T; Dezaki K; Sone H; Koizumi M; Damdindorj B; Nakata M; Kakei M
    Curr Diabetes Rev; 2008 Feb; 4(1):18-23. PubMed ID: 18220691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical perspectives for ghrelin-derived therapeutic products.
    Allas S; Abribat T
    Endocr Dev; 2013; 25():157-66. PubMed ID: 23652401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation.
    Howick K; Griffin BT; Cryan JF; Schellekens H
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ghrelin and the growth hormone secretagogue receptor in growth and development.
    Chanoine JP; De Waele K; Walia P
    Int J Obes (Lond); 2009 Apr; 33 Suppl 1():S48-52. PubMed ID: 19363508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GSK1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogs.
    Costantini VJ; Vicentini E; Sabbatini FM; Valerio E; Lepore S; Tessari M; Sartori M; Michielin F; Melotto S; Bifone A; Pich EM; Corsi M
    Neuroendocrinology; 2011; 94(2):158-68. PubMed ID: 21778696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.